Omnimmune Holdings Stock Performance
| OMMH Stock | USD 0.0001 0.00 0.000003% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Omnimmune Holdings are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Omnimmune Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong primary indicators, Omnimmune Holdings is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Last Split Factor 3:1 | Last Split Date 2008-07-01 |
Omnimmune | Build AI portfolio with Omnimmune Stock |
Omnimmune Holdings Relative Risk vs. Return Landscape
If you would invest 0.01 in Omnimmune Holdings on November 22, 2025 and sell it today you would lose 0.00 from holding Omnimmune Holdings or give up 0.0% of portfolio value over 90 days. Omnimmune Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Omnimmune, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Omnimmune Holdings Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Omnimmune Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Omnimmune Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Omnimmune Holdings generated a negative expected return over the last 90 days | |
| Omnimmune Holdings has some characteristics of a very speculative penny stock | |
| Omnimmune Holdings currently holds 987.05 K in liabilities. Omnimmune Holdings has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Omnimmune Holdings' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Omnimmune Holdings currently holds about 4.8 K in cash with (252.43 K) of positive cash flow from operations. | |
| Omnimmune Holdings has a very weak financial position based on the latest SEC disclosures |
Omnimmune Holdings Fundamentals Growth
Omnimmune Stock prices reflect investors' perceptions of the future prospects and financial health of Omnimmune Holdings, and Omnimmune Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omnimmune Stock performance.
| Return On Asset | -20.76 | ||||
| Current Valuation | 31.38 K | ||||
| Shares Outstanding | 9.81 M | ||||
| Price To Earning | (0.02) X | ||||
| Price To Sales | 5,008 X | ||||
| Net Income | (1.76 M) | ||||
| Cash And Equivalents | 4.8 K | ||||
| Total Debt | 987.05 K | ||||
| Current Ratio | 0.01 X | ||||
| Book Value Per Share | (0.61) X | ||||
| Cash Flow From Operations | (252.43 K) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 980 | ||||
| Total Asset | 31.43 K | ||||
| Retained Earnings | (21.1 M) | ||||
| Working Capital | (4.67 M) | ||||
| Current Asset | 44 K | ||||
| Current Liabilities | 4.71 M | ||||
About Omnimmune Holdings Performance
By evaluating Omnimmune Holdings' fundamental ratios, stakeholders can gain valuable insights into Omnimmune Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Omnimmune Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Omnimmune Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (64.44) | (67.66) | |
| Return On Capital Employed | 0.31 | 0.57 | |
| Return On Assets | (64.44) | (67.66) | |
| Return On Equity | 0.29 | 0.34 |
Things to note about Omnimmune Holdings performance evaluation
Checking the ongoing alerts about Omnimmune Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omnimmune Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Omnimmune Holdings generated a negative expected return over the last 90 days | |
| Omnimmune Holdings has some characteristics of a very speculative penny stock | |
| Omnimmune Holdings currently holds 987.05 K in liabilities. Omnimmune Holdings has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Omnimmune Holdings' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (1.76 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Omnimmune Holdings currently holds about 4.8 K in cash with (252.43 K) of positive cash flow from operations. | |
| Omnimmune Holdings has a very weak financial position based on the latest SEC disclosures |
- Analyzing Omnimmune Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omnimmune Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Omnimmune Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Omnimmune Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omnimmune Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Omnimmune Holdings' stock. These opinions can provide insight into Omnimmune Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Omnimmune Stock analysis
When running Omnimmune Holdings' price analysis, check to measure Omnimmune Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnimmune Holdings is operating at the current time. Most of Omnimmune Holdings' value examination focuses on studying past and present price action to predict the probability of Omnimmune Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnimmune Holdings' price. Additionally, you may evaluate how the addition of Omnimmune Holdings to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |